{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.71 vs. cons $1.68",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.82B vs. cons $4.80B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Underlying orders growth",
      "prediction": "BEAT",
      "answer": "pred ~5.5% vs. cons 5.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$6.55 midpoint vs. cons $6.49 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$1.84 midpoint vs. cons $1.81 (Q4 FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Underlying sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.0% vs. cons 3.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Free cash flow",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.55B midpoint vs. cons $3.55B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.8,
  "day5_path": "FADE",
  "day5_rationale": "The initial reaction benefits from predicted EPS of ~$1.71 versus $1.68 consensus and a FY2026 guide midpoint of ~$6.55 versus $6.49 consensus, but the implied Q4 outlook of ~$1.84 versus $1.81 provides only modest out-period estimate upside; the pre-earnings rally and elevated valuation should limit follow-through.",
  "day5_confidence": "MEDIUM"
}